SPRINGFIELD – Treatments for Alzheimer’s disease will become more accessible thanks to a new law championed by State Senator Laura Murphy.

“An Alzheimer’s diagnosis can leave a person and their loved ones feeling like their lives have been turned upside down, but knowing that they have access to the treatments that they need can be a relief,” said Murphy (D-Des Plaines). “Early treatment can significantly enhance the patient’s well-being and provide valuable time for families to adapt and plan for the future.”

The measure will require the State Employees Group Insurance Program to cover all medically necessary FDA-approved treatments and medications prescribed to slow the progression of Alzheimer’s disease. Under the new law, diagnostic testing for a physician to determine the appropriate course of treatment will also be covered.

Many FDA-approved treatments are most effective in the early stages of the disease, but roadblocks such as step therapy, which requires patients to try alternative treatments before they can access the one prescribed by their doctor, can delay or prevent those in the early stages of Alzheimer’s from receiving those treatments. To eliminate this barrier, Murphy’s law requires these treatments to be accessible without being subject to step therapy.

“Ensuring Alzheimer’s patients receive treatment as soon as possible is crucial for slowing the disease’s progression and improving their quality of life,” said Murphy. “Through this new law, we are recognizing the urgency of addressing the complex needs of patients and giving them more time with their friends and loved ones.”

Senate Bill 3318 was signed into law by the governor on Friday and takes effect Jan. 1, 2025.